Cystatin M/E may modulate malignant properties of human breast carcinoma cells (MDA-MB-435S cells) partly through the downregulation of two major secreted signaling molecules, autotaxin/lyso-phospholipase D and interleukin-8, which combine mitogenic, motogenic and angiogenic properties [94]. This evidence concerns the gene CST6 and breast carcinoma.